Upload
dinhque
View
224
Download
2
Embed Size (px)
Citation preview
Therapeutic Clinical Trials Accrual
* TJUH Accruals Only, does not contain JCN accrual data.
0
50
100
150
200
250
300
2003 2004 2005 2006
Industrial/Pharmaceutical Trials
National Cooperative group Trials
Investigator Iniitiated Trials
TJUH Clinical Trials 2006 (to date) Therapeutic Accrual by Enrolling MD
4Shari Rudoler M.D.#154John Wagner M.D.#144Joanne Filicko M.D.#138Rajnish Mago M.D.#128Bijoyesh Mookerjee M.D.#119Neal Flomenberg M.D.#109Adam Dicker M.D.,Ph.D.#9
10Rita Axelrod M.D.#810Richard Valicenti M.D.#718Pramila Anne M.D.#618Edith Mitchell M.D.#519Takami Sato M.D.#434Maria Werner-Wasik M.D.#335Mitchell Machtay M.D.#242Walter Curran M.D.#1
TJUH Clinical Trials2006 (to date) IIT Accrual by Trial
Analysis of Donor Cells Engrafted in Recipients of AllogeneicHematopoietic Stem Cell Transplantation
18Non-T#5
A Phase 1 Study of the Combination of VELCADE andChemoradiation for the Treatment of Patients
29Therap#4
Comparison of Two Forms of Immobilization of the Head forFractioned Sterotactic Radiotherapy
39Therap#3
A Research Database for Allogeneic and AutologousHematopoietic Progentior Cell Transplantation
53Non-T#2
Guanylyl Cyclase C in Blood and Colorectal Cancer63Non-T#1
Trial TitleAccrualType
TJUH Clinical Trials2006 (to date) IIT Accrual by Trial
Protocol for a Research Sample Repository for AllogeneicUnrelated Hematopoietic Stem Cell Transplantation11Non-T#9
A Pilot Study Investigating Active Breathing Control (ABC) toReduce Radiation Dose to Normal Structures in Breast CancerPatients15Therap#8
Utility of Guanylyl Cyclase C as a Biomarker for Staging PatientsWith Colorectal Cancer15Non-T#7
Molecular Staging of Esophageal Cancer using Guanylyl CyclaseC and Cdx217Non-T#6
Trial TitleAccrua
lType
TJUH Clinical Trials2006 (to date) Therapeutic Accrual by Trial
A Phase I/II Study of LLME Treated Non-Myeloablative AllogeneicHematopoietic Stem Cell Transplantation for Patients withHematological Malignancies
10IIT#5
M-Vax: A feasibility and bio-equivalence study using a DNP-modified autologous melanoma tumor cell vaccine as therapy inpts. with stage III or IV
11Ind#4
A Pilot Study Investigating Active Breathing Control (ABC) toReduce Radiation Dose to Normal Structures in Breast CancerPatients
15IIT#3
A Phase 1, Open-Label, Dose-Escalation, Safety Study of theCombination of VELCADE and Chemoradiation for the Treatment ofPatients with Cancer
29IIT#2
A Randomized Trial Comparing Two Forms of Immobilization of theHead for Fractioned Sterotactic Radiotherapy
39IIT#1
Trial TitleAccru
alType
TJUH Clinical Trials2006 (to date) Therapeutic Accrual by Trial
A Clinical Trial of Chemotherapy and Bevacizumab with and withoutPanitumumab in the First-line Treatment of Subjects with MetastaticColorectal Cancer
7Ind#10
A Pilot Study of the Efficacy and Tolerability of Bupropion ExtendedRelease (Wellbutrin XL) for the Treatment of Major DepressiveDisorder in Women with Breast Cancer
8Ind#9
Immunoembolization of Hepatic Artery with Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)8IIT#8
A Randomized Phase III Study of Conventional Whole BreastIrradiation (WBI) versus Partial Breast Irradiation (PBI) for Womenwith Stage 0, I, II Breast Cancer
9RTOG#7
A Phase 1, Open-Label, Dose-Escalation, Safety Study of theCombination of EPO906 and Radiation Therapy (IND#67,253)10IIT#6
Trial TitleAccru
alType
TJUH Clinical Trials2006 (to date) Non-Therapeutic Accrual by Trial
Prospective, Longitudinal, Multi-Center, Descriptive Registry ofPatients Receiving Therapy Other than Surgical Resection Alone forNewly Diagnosed Head and Neck Carcinoma.
16Ind#5
Molecular Staging of Esophageal Cancer using Guanylyl Cyclase Cand Cdx217IIT#4
Analysis of Donor Cells Engrafted in Recipients of AllogeneicHematopoietic Stem Cell Transplantation
18IIT#3
A Research Database for Allogeneic and Autologous HematopoieticProgentior Cell Transplantation
53IIT#2
Guanylyl Cyclase C in Blood and Colorectal Cancer63IIT#1Trial TitleAccrualType
TJUH Clinical Trials2006 (to date) Non-Therapeutic Accrual by Trial
Analysis of Donor Cells in Allogeneic Hematopoietic Stem CellTransplantation10IIT#9
Protocol for a Research Sample Repository for Allogeneic UnrelatedHematopoietic Stem Cell Transplantation
11IIT#8
Bio-Behavioral Pathways in Oral Lesions14Coop#7
Utility of Guanylyl Cyclase C as a Biomarker for Staging Patients WithColorectal Cancer: GCC Staging of Lymph Nodes Havested DuringColorectal Cancer Surgery: Evaluating Patients For Time toRecurrence""
15IIT#6
Trial TitleAccrua
lType
JCN Clinical TrialsAccrual by Year: Therapeutic vs Not-Therapeutic
0
20
40
60
80
100
120
2004 2005 2006
NTT
JCN Clinical Trials2006 (to date) Accrual by Institution
0 5 1 0 1 5 2 0 2 5
Mercy Fitzgerald Hospital
Albert Einstein Medical Center
Riddle Hospital
Pocono Medical Center
Ephrata Hospital
Northeast Radiation Oncology Center
Frankford Hospital
Hematology & Oncology Assoc of NE PA
JCN Clinical Trials2006 (to date) Accrual by Trial
A Randomized Study of Intermittent Capecitabine incombination with Oxaliplatin (XELOX Q3W) and Bevacizumabversus Intermittent Capecitabine in Combination with Oxaliplatin(XELOX Q2W) and Bevacizumab
4Ind#5
RTOG #P-0126- A Phase III Randomized Study of High Dose 3D-CRT in Patients Treated for Localized Prostate Cancer7RTOG#4
A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxiplatin (mFOLFOX6) Every Two Weekswith Bevacizumab to the Same Regimen Without Bevacizumabfor the Treatment of Patients with Resected Stages II and IIICarcinoma of
11NSABP#3
(CIRB) A Phase III, Adjuvant Trial Comparing ThreeChemotherapy Regimens in Women with Node-Positive BreastCancer11NSABP#2
A Randomized Phase III Study of Conventional Whole BreastIrradiation (WBI) versus Partial Breast Irradiation (PBI) forWomen with Stage 0, I, II Breast Cancer
15RTOG#1
Trial TitleAccrualType
JCN Clinical Trials2006 (to date) Accrual by Trial
A Phase III Randomized, Double-Blind Study of AdjuvantST1571 (Gleevec) Versus Placebo in Patients Following theResection of Primary Gastrointestinal Stromal Tumor
3ECOG#10
A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRTin Patients with Favorable-Risk Prostate Cancer
3RTOG#9
A Clinical Trial Comparing Six Cycles of 5-Fluorouracil,Epirubicin, and Cyclophosphamide (FEC) to Four Cycles ofAdriamycin and Cyclophosphamide in Patients with Node-Negative Breast Cancer
3NSABP#8
Sequencing Topoisomerase Inhibitors for Extensive StageSmall Cell Lung Cancer (SCLC): Topotecan Sequenced withEtoposide/Cisplatin, and Irinotecan/Cisplatin with Etoposide
3ECOG#7
A Randomized Phase III Trial of Concurrent AcceleratedRadiation and Cisplatin Versus Concurrent AcceleratedRadiation, Cisplatin, and Cetuximab (C225) For Stage III andIV Head and Neck Carcinomas
4RTOG#6
Trial TitleAccrualType